Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in…

Overview of attention for article published in Arthritis Research & Therapy, September 2005

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 175 Dimensions

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α

Grant US-11897951-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.